The AI-driven biotech has secured FDA alignment on a pivotal trial for its FAP therapy, with a study start planned for 2027.
Recursion announces FDA alignment for REC-4881’s Phase 3 trial in familial adenomatous polyposis, targeting crucial adenoma excision outcomes.
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy ...
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic ...
Learn about the Sashiko open-source, agentic code review system that the Google AI & Infrastructure team built to help Linux ...
The discovery by security company Calif shows A.I.’s ability to find gaping security holes in popular software. The Java flaw ...
Java4Shell (CVE-2026-114938) is a critical OpenJDK Base64 decoder bug that can lead to RCE. See who’s affected, how to check ...
A Beginner's Guide to the Sliding Window Algorithm with JavaScript Learn the basics of the Sliding Window algorithm in ...
Deception is moving at machine speed. Learn to keep pace. On October 8, 2026, we reported that threat actors were exploiting CVE-2026-105133 and CVE-2026-105134 in AhsayCBS to drop webshells and an ...
Some PC utilities solve problems I didn't even know had a better solution. DocFetcher is one such discovery. It's a free, ...
Recursive Flint is a 40B MoE local coding model with 2.5B active parameters, scoring 74.2% on SWE-bench Verified.
Startup Recursive has released Flint, a free, laptop-sized coding model built largely by its own AI research system, as an early test of AI that improves itself.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results